These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 24004112
1. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer. Alkam Y, Mitomi H, Nakai K, Himuro T, Saito T, Takahashi M, Arakawa A, Yao T, Saito M. Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112 [Abstract] [Full Text] [Related]
2. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G. Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688 [Abstract] [Full Text] [Related]
3. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH. Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233 [Abstract] [Full Text] [Related]
4. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM. Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174 [Abstract] [Full Text] [Related]
5. Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients. Nakai K, Mitomi H, Alkam Y, Arakawa A, Yao T, Tokuda E, Saito M, Kasumi F. Cancer Chemother Pharmacol; 2012 Apr; 69(4):923-30. PubMed ID: 22083523 [Abstract] [Full Text] [Related]
6. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R. Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789 [Abstract] [Full Text] [Related]
7. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer. Xiong HL, Liu XQ, Sun AH, He Y, Li J, Xia Y. Asian Pac J Cancer Prev; 2013 Jul 17; 14(5):3139-42. PubMed ID: 23803092 [Abstract] [Full Text] [Related]
8. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma. Michailidi C, Theocharis S, Tsourouflis G, Pletsa V, Kouraklis G, Patsouris E, Papavassiliou AG, Troungos C. Exp Biol Med (Maywood); 2015 Dec 17; 240(12):1599-605. PubMed ID: 25908636 [Abstract] [Full Text] [Related]
10. Correlation of chromosome damage and promoter methylation status of the DNA repair genes MGMT and hMLH1 in Chinese vinyl chloride monomer (VCM)-exposed workers. Wu F, Liu J, Qiu YL, Wang W, Zhu SM, Sun P, Miao WB, Li YL, Brandt-Rauf PW, Xia ZL. Int J Occup Med Environ Health; 2013 Mar 17; 26(1):173-82. PubMed ID: 23412991 [Abstract] [Full Text] [Related]
11. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma. Saetta AA, Aroni K, Stamatelli A, Lazaris AC, Patsouris E. Arch Dermatol Res; 2005 Sep 17; 297(3):99-107. PubMed ID: 16012876 [Abstract] [Full Text] [Related]
13. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients. Fumagalli C, Pruneri G, Possanzini P, Manzotti M, Barile M, Feroce I, Colleoni M, Bonanni B, Maisonneuve P, Radice P, Viale G, Barberis M. Breast Cancer Res Treat; 2012 Jul 17; 134(1):131-7. PubMed ID: 22228432 [Abstract] [Full Text] [Related]
14. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR. Clin Cancer Res; 2008 May 01; 14(9):2560-9. PubMed ID: 18451217 [Abstract] [Full Text] [Related]
15. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. Tzao C, Hsu HS, Sun GH, Lai HL, Wang YC, Tung HJ, Yu CP, Cheng YL, Lee SC. J Thorac Cardiovasc Surg; 2005 Nov 01; 130(5):1371. PubMed ID: 16256791 [Abstract] [Full Text] [Related]
16. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schär P. Oncogene; 2009 Feb 12; 28(6):899-909. PubMed ID: 19060925 [Abstract] [Full Text] [Related]
17. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma. Stark AM, Doukas A, Hugo HH, Hedderich J, Hattermann K, Maximilian Mehdorn H, Held-Feindt J. Neurol Res; 2015 Feb 12; 37(2):95-105. PubMed ID: 24995467 [Abstract] [Full Text] [Related]
19. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer. Jin J, Xie L, Xie CH, Zhou YF. Genet Mol Res; 2014 May 30; 13(2):4140-5. PubMed ID: 24938706 [Abstract] [Full Text] [Related]
20. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer. Kitajima Y, Miyazaki K, Matsukura S, Tanaka M, Sekiguchi M. Gastric Cancer; 2003 May 30; 6(2):86-95. PubMed ID: 12861399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]